Exviera (dasabuvir) / AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Exviera (dasabuvir) / AbbVie
NCT00696904: Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects

Completed
1
133
NA
ABT-333, Placebo
AbbVie
HCV Infection
02/09
 
NCT00768690: A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333

Completed
1
45
US
ABT-333, ketoconazole, placebo
Abbott
HCV Infection
02/09
 
NCT00895102: Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers

Completed
1
34
US
ABT-333 Tablet, ABT-333, Placebo, ABT-333 Capsule
Abbott
HCV Infection
06/09
 
NCT00909636: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet

Completed
1
24
US
ABT-333, Placebo
Abbott
HCV Infection
07/09
 
NCT00919490: A Study of Single Dose of ABT-333 in Healthy Male Adults

Completed
1
39
Japan
ABT-333, Placebo
Abbott, Abbott Japan Co.,Ltd
HCV Infections
08/09
 
NCT02052349: Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects

Completed
1
12
Europe
ABT-333
AbbVie
Relative Bioavailability
12/13
12/13
NCT02534870: Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects

Completed
1
18
RoW
ABT-450/r/ABT-267, Paritaprevir/Ritonavir/Ombitasvir, ABT-333, Dasabuvir
AbbVie
Healthy Volunteer
09/15
09/15

Download Options